Aktuelle medikamentöse Ansätze bei Endometriose
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This review discusses current pharmacological approaches for treating endometriosis, covering hormonal therapies, analgesics, and novel therapeutic strategies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Aktualisierte Leitlinie zur Endometriose via openalex
- Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis via openalex
- Diagnostic accuracy of transvaginal ultrasound for detection of endometriosis using International Deep Endometriosis Analysis (IDEA) approach: prospective international pilot study via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex
- Effects of dienogest treatment on endometrioma-related clinical symptoms and endometrioma size: retrospective cohort study via openalex
- Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis via openalex
- Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis via openalex
- Levonorgestrel intrauterine system versus dienogest effect on quality of life of women with deep endometriosis: a randomized open-label clinical trial via openalex
- Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3) via openalex
- Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial via openalex
- Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability via openalex
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- O-269 Long term efficacy of Linzagolix in women with endometriosis-associated pain via openalex
- Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
- Oral contraceptives for pain associated with endometriosis via openalex
- The Effect of Neuromodulatory Drugs on the Intensity of Chronic Pelvic Pain in Women: A Systematic Review via openalex
- Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial via openalex
- Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study via openalex
- Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence via openalex
- Use of dienogest in endometriosis: a narrative literature review and expert commentary via openalex
- W4388419566 via openalex
- W2079421112 via openalex
- W4387867257 via openalex
- W3194419458 via openalex
- W4408247999 via openalex
- W2109711640 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-05T02:00:03.366016+00:00
License: CC0
· commercial use OK